Results
1 -
10 of
20
(Click
here to explore results)
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 5 Pharmacogenomics and Epigenomics of Age-Related Neurodegenerative Disorders: Strategies for Drug Development. Ramón Cacabelos, Juan Carlos Carril, Oscar Teijido
, 2017
, Pages 75-141
- Epigenetics for Drug Discovery, CHAPTER 9 Who will Benefit from Epigenetic Drugs?. Dominique Verhelle, David J. Shields
, 2016
, Pages 230-248
- Natural Product Chemistry for Drug Discovery, Chapter 11 A Snapshot of Natural Product-Derived Compounds in Late Stage Clinical Development at the End of 2008. Mark S. Butler
, 2009
, Pages 321-354
- Orphan Drugs and Rare Diseases, Chapter 11 Drug Discovery Approaches for Rare Neuromuscular Diseases. Graham M. Wynne, Angela J. Russell
, 2014
, Pages 257-343
- Polyamine Drug Discovery, Chapter 10 The Design and Development of Polyamine-Based Analogs with Epigenetic Targets. Yi Huang, Laurence J. Marton, Patrick M. Woster
, 2012
, Pages 238-256
- Anti-aging Drugs: From Basic Research to Clinical Practice, CHAPTER 21 HDAC Inhibitors: A New Avenue in Anti-Aging Medicine. E. G. Pasyukova, A. M. Vaiserman
, 2017
, Pages 514-534
- Epigenetics for Drug Discovery, CHAPTER 5 Targeting Histone Acetylation. Daniel Vitt, Roland Baumgartner, Hella Kohlhof
, 2016
, Pages 96-126
- Supramolecular Chemistry in Biomedical Imaging, CHAPTER 7 Molecular Imaging in Diagnosis and Treatment of Brain Tumours. Nicola J. Farrer, Rhiannon J. Evans, Sophie V. Morse, Nicholas J. Long
, 2022
, Pages 207-241
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 12 The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation. Annerleim Walton-Diaz, Sahar Khan, Jane B. Trepel, Mehdi Mollapour, Len Neckers
, 2014
, Pages 318-335
- Designing Multi-Target Drugs, Chapter 14 Discovery of HDAC-Inhibiting Multi-Target Inhibitors. Xiong Cai, Changgeng Qian
, 2012
, Pages 221-242